Navigation Links
Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
Date:1/27/2009

First and Only Topical Gel Provides Ease, Efficacy and Excellent Tolerability

CORONA, Calif., Jan. 27 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leader in generic and specialty branded pharmaceuticals, announced today that the U.S. Food and Drug Administration (FDA) has approved GELNIQUE(TM) (oxybutynin chloride) Gel 10%, the first and only topical gel for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency. The U.S. OAB market currently exceeds $1.8 billion annually and continues to grow each year.

GELNIQUE will provide OAB patients with an effective and novel alternative to currently available oral treatment options. Because the active ingredient in GELNIQUE is delivered transdermally, it is not metabolized by the liver in the same way as orally administered oxybutynin. This results in a low level of side effects, such as dry mouth and constipation. GELNIQUE will be actively marketed to physicians, and Watson anticipates that the product will be made available to patients in the second quarter of this year.

"Based on the results of a clinical trial, which showed strong efficacy and excellent tolerability, and considering its unique delivery system, we expect that GELNIQUE will be used as a first-line therapy for the treatment of OAB," said Paul Bisaro, Chief Executive Officer of Watson. He added, "With this approval, which comes on the heels of the FDA approval of RAPAFLOTM (silodosin), a treatment for the signs and symptoms of benign prostatic hyperplasia (BPH), and the acceptance of the NDA for Watson's six-month formulation of TRELSTAR(R) for the palliative treatment of advanced prostate cancer, Watson is clearly establishing itself as a major force in Urology."

About GELNIQUE

GELNIQUE is a q
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU
2. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
3. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
4. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
5. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
6. Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
7. EVICEL(TM) Fibrin Sealant (Human) Approved for General Hemostasis in Surgery
8. Clexane(R)/Lovenox(R) Approved in Japan
9. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
10. Center for Molecular Medicine Among First to Offer New FDA-Approved Test to Aid in Treatment of Prostate Cancer
11. Lucids VivaScope(R) Reflective Confocal Microscope Approved for Sale in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Calif. , May 17, 2013  Cellular ... has achieved 50% enrollment of the total projected ... evaluate the safety and preliminary efficacy of the ... therapy for Knee Osteoarthritis (KOA). To date the ... reported. The Phase I open label ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Men’s skin is ... La-roche Posay ) and has been known to react ... some men may be far from puberty, other acne causing ... pores, causing breakouts, and threatening skin with unsightly acne scars. ... from Men’s Health on how to reduce and ...
(Date:5/17/2013)... 2013 IAC Industries wants to share with ... laboratory needing to set up and furnish a research lab ... facility within a year’s time. How does a company make ... is temporary? What is efficient and cost-effective? , The ... IAC Industries. The planners at DisperSol determined that the concept ...
(Date:5/16/2013)... 2013 Oven Industries, Inc. has been ... and temperature sensors since 1964. Expertly designed, the ... control system applications. As one of the ... generic, control loop feedback system, which helps minimize errors. ... adjust a systematic process, using a control element, like ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2New PID Temperature Controllers Announced by Oven Industries Inc. 2
... , , , , , from rat lung, recombinant, , , ... , Catalog Number, Pack Size, ... 2000 units, , , 3335402, ... , , , , , , Package Inserts/Product , Instructions, ...
... carry-over prevention Cat. No. 1 585 541 , (1 Kit = 50 reactions) , ... , , The PCR Core Kit PLUS supplies all basic reagents to perform ... and appropriate primers. The kit contains: , , ... Taq DNA Polymerase , PCR Nucleotide MixPLUS , ...
... Polymerase for two-step RT-PCR amplification of up to 4 kb targets , ... , , , , , ... C. therm. Polymerase provided by Roche Applied Science is the recombinant , ... hydrogenoformans, expressed in E. coli. The recombinant enzyme lacks the , ...
Cached Biology Technology:PCR Core KitPLUS 2C. therm. Polymerase for Reverse Transcription in Two-Step RT-PCR 2
(Date:5/17/2013)... Efficient and Sustainable Global Logistics Operations) is aiming to ... efficiency of intermodal loading systems and the boosting of ... European organisations with experience in the logistics sector and ... 17,000,000 and a duration of three and a half ... the semantic components and ontologies shared by the users, ...
(Date:5/17/2013)... Societies for Experimental Biology (FASEB) released a new ... trends highlighting the devastating impact of sequestration on the ... follows a May 15th Senate Appropriations Committee hearing featuring ... the $1.6 billion cut the agency sustained in FY ... on the scientific community." , According to data ...
(Date:5/16/2013)... Bethesda, MD (May 17, 2013) Illustrating a ... the American Gastroenterological Association (AGA) Research Foundation ... Future Student Research Fellowship Award recipients. Supported by ... Kidney Diseases (NIDDK), this new award helps underrepresented ... digestive disease and nutrition research. , "By establishing ...
Breaking Biology News(10 mins):New logistics services that will cut energy consumption and CO2 emissions 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
... MAOne of the big, unsolved problems in explaining how ... could the basic biochemicalssuch as amino acids and nucleotideshave ... to carry out their formation? In a paper ... Bulletin, scientists propose that a third type of ...
... This release is available in Spanish . ... of fungi on peanuts, can be used on corn as ... (USDA) scientists who helped develop it. After extensive ... the U.S. Environmental Protection Agency (EPA) for use on corn, ...
... Researchers at Yale School of Medicine have developed a ... of eventually treating people with the disorder. Hemophilia A, a ... by a variety of mutations in the factor VIII gene. ... the study aimed to provide a better understanding of hemophilia ...
Cached Biology News:Transition metal catalysts could be key to origin of life, scientists report 2Transition metal catalysts could be key to origin of life, scientists report 3Yale develops new animal model for hemophilia A 2
RABBIT ANTI NEOPTERIN...
MOUSE ANTI SIMIAN VIRUS 5:FITC Immunogen: Simian virus 5...
... Dog Serum-Mixed Breed • Dog serum is collected ... one year of age Available Anticoagulants: ... (Na) N-06: K2EDTA N-08: ... N-03: Alsevers N-05: ACD ...
Collected from normal, healthy animals in carefully maintained standing herds of US orgin. Pricing: $45/unit for 1 - 10 units...
Biology Products: